Get startedLog in
    Picture of China Shineway Pharmaceutical logo

    2877 — China Shineway Pharmaceutical Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for China Shineway Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M—
    Source:ARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS    		—
    Status:FinalFinalFinalFinal
    fx
    Preliminary
    Net Income/Starting Line3957209171,240—
    Depreciation
    Amortisation
    Non-Cash Items116-98-126-120—
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-81.1-101133-365—
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities6397031,110933—
    Capital Expenditures-66-93.6-129-144—
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-2404898494.8—
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-306395-45.4-49.5—
    Financing Cash Flow Items-54.61.17-0.63-2.6—
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-330-829-250-26.7—
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-3263821863—